Clemenz M - Search Results

1

PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.

Clasen R, Schupp M, Foryst-Ludwig A, Sprang C, Clemenz M, Krikov M, Thöne-Reineke C, Unger T, Kintscher U. Clasen R, et al. Among authors: clemenz m. Hypertension. 2005 Jul;46(1):137-43. doi: 10.1161/01.HYP.0000168046.19884.6a. Epub 2005 Jun 6. Hypertension. 2005. PMID: 15939809

2

Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity.

Schupp M, Clemenz M, Gineste R, Witt H, Janke J, Helleboid S, Hennuyer N, Ruiz P, Unger T, Staels B, Kintscher U. Schupp M, et al. Among authors: clemenz m. Diabetes. 2005 Dec;54(12):3442-52. doi: 10.2337/diabetes.54.12.3442. Diabetes. 2005. PMID: 16306360

3

Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.

Clemenz M, Frost N, Schupp M, Caron S, Foryst-Ludwig A, Böhm C, Hartge M, Gust R, Staels B, Unger T, Kintscher U. Clemenz M, et al. Diabetes. 2008 May;57(5):1405-13. doi: 10.2337/db07-0839. Epub 2008 Jan 9. Diabetes. 2008. PMID: 18184928

4

Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.

Foryst-Ludwig A, Clemenz M, Hohmann S, Hartge M, Sprang C, Frost N, Krikov M, Bhanot S, Barros R, Morani A, Gustafsson JA, Unger T, Kintscher U. Foryst-Ludwig A, et al. Among authors: clemenz m. PLoS Genet. 2008 Jun 27;4(6):e1000108. doi: 10.1371/journal.pgen.1000108. PLoS Genet. 2008. PMID: 18584035 Free PMC article.

5

PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice.

Foryst-Ludwig A, Hartge M, Clemenz M, Sprang C, Hess K, Marx N, Unger T, Kintscher U. Foryst-Ludwig A, et al. Among authors: clemenz m. Cardiovasc Diabetol. 2010 Oct 18;9:64. doi: 10.1186/1475-2840-9-64. Cardiovasc Diabetol. 2010. PMID: 20955583 Free PMC article.

6

The metabolic syndrome: cluster with a self-fulfilling loop?

Clemenz M, Kintscher U, Unger T. Clemenz M, et al. J Hypertens. 2006 Feb;24(2):257-8. doi: 10.1097/01.hjh.0000202813.79964.4a. J Hypertens. 2006. PMID: 16508565 No abstract available.

7

Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan.

Goebel M, Clemenz M, Unger T. Goebel M, et al. Among authors: clemenz m. Expert Rev Cardiovasc Ther. 2006 Sep;4(5):615-29. doi: 10.1586/14779072.4.5.615. Expert Rev Cardiovasc Ther. 2006. PMID: 17081084 Review.

8

Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma.

Walcher D, Hess K, Heinz P, Petscher K, Vasic D, Kintscher U, Clemenz M, Hartge M, Raps K, Hombach V, Marx N. Walcher D, et al. Among authors: clemenz m. Hypertension. 2008 Feb;51(2):259-66. doi: 10.1161/HYPERTENSIONAHA.107.099028. Epub 2007 Dec 24. Hypertension. 2008. PMID: 18158351

9

Characterization of new PPARgamma agonists: analysis of telmisartan's structural components.

Goebel M, Clemenz M, Staels B, Unger T, Kintscher U, Gust R. Goebel M, et al. Among authors: clemenz m. ChemMedChem. 2009 Mar;4(3):445-56. doi: 10.1002/cmdc.200800285. ChemMedChem. 2009. PMID: 19197922

10

Sexual dimorphism in obesity-mediated left ventricular hypertrophy.

Böhm C, Benz V, Clemenz M, Sprang C, Höft B, Kintscher U, Foryst-Ludwig A. Böhm C, et al. Among authors: clemenz m. Am J Physiol Heart Circ Physiol. 2013 Jul 15;305(2):H211-8. doi: 10.1152/ajpheart.00593.2012. Epub 2013 May 10. Am J Physiol Heart Circ Physiol. 2013. PMID: 23666673 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters